Skip to content

Using precise cTBS to stimulate gait-related targets in supplementary motor area to improve gait disorders in patients with Parkinson's disease

Using precise cTBS to stimulate gait-related targets in supplementary motor area to improve gait disorders in patients with Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082558
Enrollment
Unknown
Registered
2024-04-01
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

real group:Real cTBS therapy is performed on the target. Three sets of cTBS treatment were performed daily, during which a 15-minute rest was taken for each completion, followed by a second set of tre
Sham group:Sham cTBS therapy is performed on the target. Three sets of cTBS treatment were performed daily, during which a 15-minute rest was taken for each completion, followed by a second set of tre

Sponsors

the Affiliated Hospital of Hangzhou Normal University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with sporadic Parkinson's disease who met the diagnostic criteria for MDS and experienced at least one frozen gait in the last 1 month; (2) Age 40-75 years old; (3) During the study period, anti-Parkinson's drugs were not adjusted (drug optimization and adjustment were carried out before the study); (4) Hoehn-Yahr stages 2-4; (5) MMSE score ?26 points; (6) There were no injuries to both lower limbs and no MRI contraindications; (7) No stereotactic surgery was performed; (8) No other neurological or mental illness.

Exclusion criteria

Exclusion criteria: (1) secondary Parkinson's disease or Parkinson's combined syndrome; (2) severe heart, liver and renal insufficiency; (3) after deep brain stimulation or other nerve implantation; (4) Have a history of seizures; (5) Mental and psychological abnormalities, unable to cooperate with MRI scanning and TMS intervention.

Design outcomes

Primary

MeasureTime frame
functional connectivity;

Secondary

MeasureTime frame
UPDRS-III;

Countries

China

Contacts

Public ContactHu Zhengxiang

the Affiliated Hospital of Hangzhou Normal University

hu_zhengxiang@126.com+86 158 5822 2657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026